Research Topics
| Robert J GajarskiSummaryAffiliation: University of Michigan Country: USA Publications
| Collaborators
|
Detail Information
Publications
Infection and malignancy after pediatric heart transplantation: the role of induction therapyRobert J Gajarski
Division of Pediatric Cardiology, University of Michigan, CS Mott Children s Hospital, Ann Arbor, Michigan 48109, USA
J Heart Lung Transplant 30:299-308. 2011..This study hypothesized that induced pediatric patients would have an increased risk of these events compared with non-induced patients...- Adrenocortical response in infants undergoing cardiac surgery with cardiopulmonary bypass and circulatory arrestRobert J Gajarski
Department of Pediatrics, Division of Cardiology, University of Michigan Health Center, Ann Arbor, MI, USA
Pediatr Crit Care Med 11:44-51. 2010.... - Outcomes of pediatric patients with hypertrophic cardiomyopathy listed for transplantRobert Gajarski
Division of Pediatric Cardiology, C S Mott Children s Hospital, Ann Arbor, Michigan 48109, USA
J Heart Lung Transplant 28:1329-34. 2009..The course of pediatric hypertrophic cardiomyopathy (HCM) is variable, and the indications for heart transplantation (HTx) are ill defined. This study investigated outcomes and risk factors for adverse outcomes after listing for HTx... - Association of pediatric heart transplant coronary vasculopathy with abnormal hemodynamic measuresRanjit Aiyagari
C S Mott Children s Hospital, Division of Pediatric Cardiology, University of Michigan Health Center, 1500 E Medical Center Drive, Ann Arbor, MI 48109, USA
Congenit Heart Dis 6:128-33. 2011..Catheter-derived right ventricular end-diastolic pressure (RVEDP) and pulmonary capillary wedge pressure (PCWP) were recorded. Biopsies were collected to verify the absence of rejection... - A United Network for Organ Sharing analysis of heart transplantation in adults with congenital heart disease: outcomes and factors associated with mortality and retransplantationTara Karamlou
Division of Pediatric Cardiovascular Surgery, Section of Cardiac Surgery, Department of Surgery, University of Michigan, Ann Arbor, Mich, USA
J Thorac Cardiovasc Surg 140:161-8. 2010..We investigated outcomes and risk factors for mortality and retransplantation among patients with adult congenital heart disease compared with adult recipients... - Has late rejection decreased in pediatric heart transplantation in the current era? A multi-institutional studyRebecca K Ameduri
Division of Pediatric Cardiology, University of Minnesota Amplatz Children s Hospital, Minneapolis, MN 55454, USA
J Heart Lung Transplant 31:980-6. 2012..The incidence of rejection has decreased in the first year after pediatric HTx in the current era. We hypothesized a similar phenomenon has occurred with LR... - Intravenous induction of therapeutic hypothermia in the management of junctional ectopic tachycardia: a pilot studyBrendan Patrick Kelly
Department of Pediatric Cardiology, University of Michigan, Ann Arbor, MI, USA
Pediatr Cardiol 31:11-7. 2010..Intravenous induction of therapeutic hypothermia can be safely and effectively performed for children with JET. Further studies, powered for clinically relevant outcomes, should evaluate this potentially valuable therapeutic method... - Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypassMichael G Gaies
University of Michigan School of Medicine, Ann Arbor, MI, USA
Pediatr Crit Care Med 11:234-8. 2010..The goal of this study was to determine the association between inotropic/vasoactive support and clinical outcome in infants after cardiac surgery... 
Use of extracorporeal life support as a bridge to pediatric cardiac transplantationRobert J Gajarski
Division of Pediatric Cardiology, Department of Pediatrics, University of Michigan, C S Mott Children s Hospital, Ann Arbor, Michigan, USA
J Heart Lung Transplant 22:28-34. 2003..Extracorporeal life support (ECLS) has been used for post-cardiotomy rescue, but its use as a bridge to heart transplantation (OHT) in patients with post-surgical or end-stage ventricular failure remains controversial...- Pediatric coronary allograft vasculopathy--a review of pathogenesis and risk factorsKurt R Schumacher
Congenital Heart Center, University of Michigan, Ann Arbor, MI 48109, USA
Congenit Heart Dis 7:312-23. 2012..The characteristics and unique clinical findings among pediatric transplant recipients will be explored within the context of recent, albeit limited, scientific investigations... - Non-cameral coronary artery fistulae after pediatric cardiac transplantation: a multicenter studyKiona Y Allen
Department of Pediatrics, Children s Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois60637, USA
J Heart Lung Transplant 31:744-9. 2012..We studied the incidence, anatomic distribution, and natural history of non-cameral CAFs (NC-CAFs) in a multicenter pediatric population... - Relation of left ventricular diastolic function as measured by echocardiography and pulmonary capillary wedge pressure to rejection in young patients (< or = 31 years) after heart transplantationLucy Y Eun
Department of Pediatrics, Division of Pediatric Cardiology, University of Michigan, Ann Arbor, Michigan, USA
Am J Cardiol 96:857-60. 2005..02), and an elevated PCWP was associated with rejection (p = 0.023) but with poor sensitivity. Weak but insignificant correlations with PCWP were found for E/Vp (r = 0.28) and E/Em (r = 0.37)... - Effect of age on lipid profiles in pediatric heart transplant recipientsAimee K Armstrong
Division of Pediatric Cardiology, Department of Pediatrics and Communicable Diseases, University of Michigan Health System, Ann Arbor, MI 48109, USA
Pediatr Transplant 9:523-30. 2005..Once safety and efficacy data are available, all age groups may benefit from statins... - Bridge to transplant using the MicroMed DeBakey ventricular assist device in a child with idiopathic dilated cardiomyopathyMassimo A Padalino
Division of Pediatric Cardiovascular Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan, USA
Ann Thorac Surg 81:1118-21. 2006..This was the first pediatric implant of the MDBVAD in the United States and the youngest patient worldwide. The patient recovered well and subsequently underwent successful heart transplantation after 84 days of support... - Safety profile of decellularized, cryopreserved pulmonary allografts when used in the aortic position for neonatal arch reconstructionMarc D Knepp
Division of Pediatric Cardiology, C S Mott Children s Hospital, University of Michigan, Ann Arbor, MI 48109, USA
Pediatr Cardiol 32:807-10. 2011..Because this graft material, which may be less immunogenic, has important implications for this subgroup, who are at increased future transplant risk, larger trials evaluating longer-term safety and immunogenicity are warranted... - Risk factors for bleeding in pediatric post-cardiotomy patients requiring ECLSKathryn Nardell
Departments of Pediatric Cardiology, University of Michigan Health Systems, Ann Arbor, MI, USA
Perfusion 24:191-7. 2009..This retrospective review details bleeding complications and identifies risk factors for bleeding in these patients... - Lack of correlation between MMF dose and MPA level in pediatric and young adult cardiac transplant patients: does the MPA level matter?Robert J Gajarski
University of Michigan, C S Mott Children s Hospital, Department of Pediatrics, Division of Pediatric Cardiology, Ann Arbor, MI, USA
Am J Transplant 4:1495-500. 2004..An MPA trough level < 2.5 microg/mL was more frequently associated with EMB grade > or = 2. Concentration rather than dose-driven management is a more prudent strategy when using MMF...